Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1974
|
| gptkbp:approvedBy |
gptkb:Germany
|
| gptkbp:ATCCode |
gptkb:G04BD09
|
| gptkbp:bioavailability |
low (oral)
|
| gptkbp:brand |
gptkb:Regurin
gptkb:Sanctura |
| gptkbp:CASNumber |
10405-02-4
|
| gptkbp:contraindication |
narrow-angle glaucoma
|
| gptkbp:discoveredBy |
gptkb:Dr._Karl_Thomae_GmbH
|
| gptkbp:drugClass |
antimuscarinic
|
| gptkbp:eliminatedIn |
renal
|
| gptkbp:hasMolecularFormula |
C25H30NO3
|
| https://www.w3.org/2000/01/rdf-schema#label |
trospium
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
muscarinic antagonist
|
| gptkbp:metabolism |
not extensively metabolized
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
constipation
blurred vision dry mouth urinary retention |
| gptkbp:synonym |
gptkb:trospium_chloride
|
| gptkbp:usedFor |
overactive bladder
|
| gptkbp:bfsParent |
gptkb:KarXT
|
| gptkbp:bfsLayer |
6
|